Azura Ophthalmics Ltd.

Three venture capital funds announced during the last two weeks of October have $989m to invest in life science companies, which should help keep the biopharmaceutical VC financing boom going beyond 2

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Johnson & Johnson has made a big push with its JLabs life science incubators, with locations in the US biotechnology hubs of San Diego, San Francisco and Boston as well as in Houston, Texas and Toro